◆ 会议时间：2026年10月23-27日
◆ 会议地点：西班牙 马德里
◆ 会议简介：
2026年欧洲肿瘤内科学会(ESMO)年会/大会将于2026年10月23-27日在西班牙马德里举行，会议由欧洲肿瘤内科学会(ESMO)主办。欧洲肿瘤内科学会年会(ESMO大会)是欧洲最负盛名和最具影响力的肿瘤学会议，每年都有超过30,000名专业人士参加会议；届时来自世界各地的临床医生、研究人员、患者倡导者、记者和制药业人士将齐聚一堂，一起分享了解肿瘤学领域的最新进展，并将科学转化为最佳的癌症患者护理。ESMO大会科学计划将由一个300多名国际专家组成的委员会制定，内容涵盖从基础研究到癌症免疫治疗的最新发现，从肿瘤护理到姑息治疗，从罕见癌症到药物批准，等等。ESMO年度大会将成为转化研究、呈现实践变化数据宣和多学科讨论的卓越全球平台，大会将提供优秀的科学教育计划，为代表们提供了丰富的交流意见的机会。（2025ESMO年会数字：37000余名与会者来自170多个国家/地区；600余位演讲嘉宾；2900多份摘要展示）
欧洲肿瘤内科学会（ESMO）成立于1975年，是全球领先的肿瘤内科学专业组织。ESMO是肿瘤学教育和信息的参考学会，现在全球160多个国家和地区拥有超过25,000余名会员；ESMO致力于通过宣促进多学科的癌症护理，支持肿瘤学家的专业发展以及在全球倡导可持续的癌症护理，尽而为癌症患者提供最佳的护理。未经本站许可，禁止复制转载摘录镜像本站任何内容-领域国际医学会议网(lingyuint.com)。
ESMO 2026 - European Society of Medical Oncology (ESMO) Congress 2026
Date:
23-27 October 2026
Venue:
IFEMA MADRID (Madrid, Spain)
The ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care.
Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
Save the date for ESMO 2026, taking place in Madrid, Spain, on 23-27 October 2026.
摘要征文投稿：
Abstract submission deadlines-征稿截止日期
The abstract submission system will open in February 2026
Abstract submission deadlines
| Deadline |
Date and time |
- Abstracts
- Trials in Progress
- Intent to submit LBAs
|
12 May 2026, 21:00 CEST
|
|
8 September 2026, 21:00 CEST
A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on 12 May 2026. |
Abstract submission categories
- AI for diagnostics and profiling (pathology, radiology, molecular biology)
- AI for clinical workflows and decision-making
- AI for clinical research and drug development
- Basic science
- New diagnostic tools
- Pathology and molecular pathology
- Translational research and biomarkers
- Breast cancer, early stage
- Advanced breast cancer, other
- HER2+ breast cancer
- HR+ breast cancer
- Triple negative breast cancer
- CNS tumours
- Developmental therapeutics
- Biliary tract cancer, incl. cholangiocarcinoma
- Hepatocellular carcinoma (HCC)
- Oesophagogastric cancer
- Pancreatic cancer
- Colon cancer
- Rectal and anal cancer
- Germ cell (testicular) cancer and penile cancer
- Localised and locally advanced prostate cancer
- Metastatic prostate cancer
- Renal cancer
- Urothelial cancer
- Gynaecological cancers
- Haematological malignancies
- Head and neck cancer, excluding thyroid
- Investigational immunotherapy
- Melanoma
- Non-melanoma skin tumours
- Endocrine tumours
- Neuroendocrine tumours
- Thyroid cancer
- NSCLC, early stage
- NSCLC, locally advanced
- SCLC
- Thoracic malignancies, other
- NSCLC, metastatic
- Policy
- Sarcoma
- Early detection and intervention
- Primary prevention
- Secondary prevention
- Palliative care
- Psycho-oncology
- Supportive care
- Miscellaneous
- *Cancer Nursing: Digital innovation and technology in practice
- *Cancer Nursing: Equitable health care of underserved population
- *Cancer Nursing: Palliative and advanced cancer care across the cancer continuum
- *Cancer Nursing: Prevention, early detection and health promotion
- *Cancer Nursing: Supportive care and symptom management
- *Cancer Nursing: Workforce development for the future
*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nursing categories must follow all regular ESMO Congress 2026 submission regulations and guidelines.
Late-breaking abstracts (LBAs)
Late-breaking abstracts may be submitted for high quality, new research findings from prospective interventional clinical trials or observational series (large real world data sets) or novel technologies with major implications for clinical practice and/or understanding and targeting of disease processes.
The final late-breaking abstract deadline of 8 September 2026 is under no circumstances to be considered as an extension of the general submission deadline.
Presentation and publication of accepted abstracts
The ESMO Congress 2026 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Presidential Symposium – Oral presentations by authors presenting cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Rapid Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Paper poster presentation for review and discussion onsite. Presenting authors must attend the Congress in person to represent their work. Preparation of an e-Poster file is also mandatory for inclusion in the Congress Virtual Platform and onsite digital screens.
- E-Poster – Electronic poster in PDF format for inclusion in the Congress Virtual Platform and onsite digital screens. Presenting authors of ePosters are not required to attend the Congress in person to represent their work. Paper posters are not to be prepared, and poster boards will not be provided.
All accepted abstracts, will be published online in the ESMO Congress 2026 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.
ESMO Merit Award
A restricted number of ESMO Merit Awards for the ESMO Congress 2026 are available, upon application, to first authors (= presenters) who submit abstracts considered to be deserving of recognition.
Candidates must be ESMO Members under the age of 40 and indicate that they wish to be considered for a Merit Award at the time of submitting the abstract.
The selection will be made by the Scientific Committee on a competitive basis considering the scientific merit of the abstract.
下为上届信息
ESMO2025 注册费：
Registration includes:
- Admission to onsite scientific and educational sessions with the possibility to interact with Speakers, Session Chairs and panel speakers
- Networking opportunities with the congress faculty and peers
- Entry to the poster and e-poster area
- Interaction with industry partners in the trade exhibition
- Participation in the Industry Satellite Symposia
- Access to the virtual congress platform to watch the sessions live or view the content on-demand
- Post-event resources (webcasts, slides, abstracts) on OncologyPRO
Registration fees
(19% German VAT included) |
Early registration
until 16 July 2025 |
Late registration
until 10 September 2025 |
Full registration
from 11 September 2025 |
ESMO Member |
€ 665.00 |
€ 934.00 |
€ 1,195.00 |
ESMO Member Developing Countries* |
€ 185.00 |
€ 300.00 |
€ 598.00 |
ESMO Member in Training** |
€ 107.00 |
€ 140.00 |
€ 210.00 |
ESMO Member Undergraduate Student |
€ 107.00 |
€ 140.00 |
€ 210.00 |
ESMO / EONS Member Nurse |
€ 555.00 |
€ 555.00 |
€ 555.00 |
ESMO Member Patient Advocate |
€ 107.00 |
€ 140.00 |
€ 210.00 |
EONS Early Career Nurse*** |
€ 107.00 |
€ 107.00 |
€ 107.00 |
Non-Member |
€ 1,040.00 |
€ 1,315.00 |
€ 1,595.00 |
*Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO Members must be under 40 and in training to qualify for this fee.
*** EONS Cancer Nurses must be under 35 to qualify for this fee.
Other registration fees
(19% German VAT included) |
Fee |
Access |
Private Meeting badge |
€ 265.00 |
Exhibition & Satellites, private meeting & business rooms |
Industry Symposium badge |
€ 265.00 |
Exhibition & Satellites, private meeting & business rooms Exhibition & Satellites, private meeting & business rooms |
Exhibitor Visitor badge |
€ 130.00 |
Exhibition area only |
Third Party Media |
€ 700.00 |
Venue common area, filming area, private meeting and business rooms |
Please send an email to registration@esmo.org to request one of the badges in the "Other registration fees" table above.
ESMO2025-欧洲肿瘤年会-ESMO欧洲肿瘤内科学会2025-ESMO年会/大会-ESMO Congress 2025
◆ 参会对象：
肿瘤科医师、放射科医师，介入放射科医师，外科/普外科医师，病理科医师，护士以及从事肿瘤护理与研究的其他相关专业人士等。
|
